Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).

被引：0
|
作者：
Barthelemy, Philippe
Loriot, Yohann
Voog, Eric
Eymard, Jean Christophe
Ravaud, Alain
Flechon, Aude
Jaillon, Christine Abraham
Chasseray, Matthieu
Lorgis, Veronique
Hilgers, Werner
Gobert, AurElien
Le Moulec, Sylvestre
Simon, Camille
Nicolas, Emanuel
Escande, Anne
Pouessel, Damien
Josse, Constant
Solbes, Marie-Noelle
Lambert, Prisca
Thibault, Constance
机构：
[1] Inst Cancerol Strasbourg Europe, Strasbourg, France
[2] Gustave Roussy, Villejuif, France
[3] Clin Victor Hugo Ctr Jean Bernard, Le Mans, France
[4] Inst Cancerol Jean Godinot, Reims, France
[5] Bordeaux Univ, Bordeaux Univ Hosp, Bordeaux, France
[6] Ctr Leon Berard, Lyon, France
[7] Foch Hosp, Suresnes, France
[8] Ctr Finisterien Radiotherapie & Oncol Clin Pasteu, Brest, France
[9] Inst Cancerol Bourgogne, Dijon, France
[10] Avignon Provence Canc Inst, Avignon, France
[11] St Gregoire Hosp, St Gregoire, France
[12] Clin Marzet, Pau, France
[13] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
[14] Univ Hosp Nimes, Nimes, France
[15] Clin Ste Anne, Strasbourg, France
[16] Inst Claudius Regaud IUCT Oncopole, Toulouse, France
[17] eXYSTAT, Malakoff, France
[18] Merck Sante SAS, Lyon, France
[19] Pfizer Oncol, Paris, France
[20] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris CARPEM, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
    Grivas, Petros
    Barata, Pedro
    Moon, Helen
    Gupta, Shilpa
    Hutson, Thomas
    Sternberg, Cora N.
    Brown, Jason R.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard M.
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [22] Prognostic impact of first-line (1L) chemotherapy cycles in patients with metastatic urothelial carcinoma receiving avelumab 1L maintenance.
    Katayama, Satoshi
    Kawada, Tatsuhi
    Kobayashi, Keita
    Watanabe, Ryuta
    Tohi, Yoichiro
    Yamamoto, Shinkuro
    Takamoto, Atsushi
    Shimizu, Ryutaro
    Daizumoto, Kei
    Nagami, Taichi
    Wada, Koichiro
    Miura, Noriyoshi
    Morizane, Shuichi
    Furukawa, Junya
    Inoue, Keiji
    Sugimoto, Mikio
    Shiraishi, Koji
    Araki, Motoo
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [23] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    Mansinho, Andre
    Cruz, Andreia
    Marconi, Lorenzo
    Pinto, Cidalia
    Augusto, Isabel
    ADVANCES IN THERAPY, 2023, 40 (10) : 4134 - 4150
  • [24] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    André Mansinho
    Andreia Cruz
    Lorenzo Marconi
    Cidália Pinto
    Isabel Augusto
    Advances in Therapy, 2023, 40 : 4134 - 4150
  • [25] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [26] Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.
    Gridneva, Yana
    Sultanbaev, Alexander, Sr.
    Anzhiganova, Yulia
    Gluzman, Mark
    Mochalova, Anastasia
    Shkurat, Alexey
    Parsadanova, Elvira
    Israelyan, Edgar
    Murzina, Yulia
    Kalpinsky, Aleksey
    Stativko, Olesia
    Karabina, Elena
    Kfln, Artyom
    Petkau, Vladislav
    Tovbik, Natalya
    Turganova, Maria
    Safina, Sufiia
    Kopyltsov, Evgeny
    Volkova, Maria
    Tsimafeyeu, Ilya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Real-world study assessing physician rationale for initiating first-line (1L) immuno-oncology (IO) therapy for patients with advanced urothelial cancer (aUC)
    Ajmera, M.
    Chang, J.
    Hitchens, A.
    Kearney, M.
    Esterberg, E.
    Kim, R.
    Cappelleri, J.
    Devgan, G.
    Costa, N.
    Candrilli, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S715 - S716
  • [28] Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial Carcinoma
    Lapuente, Maria
    Conway, Dawn
    Wood, Laura S.
    Kehoe, Kiran
    Bullock, Andrea Carroll
    Devgan, Geeta
    Burns, Kathleen D.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (01) : 71 - 80
  • [29] Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia
    Moujaber, Tania
    Tran Ben
    Liow, Elizabeth
    Clay, Timothy
    Bennett, Geer
    Kearney, Mairead
    Gibberd, Alison
    Gurney, Howard
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 94 - 95
  • [30] Real-world effectiveness and safety of first-line (1L) avelumab plus axitinib in patients with advanced renal cell carcinoma (aRCC): Primary analysis of the AVION study.
    Merseburger, Axel Stuart
    Baklanova, Olga
    Garlonta, Victor T.
    Androulakis, Nikolaos E. M.
    Christopoulou, Athina
    Timotheadou, Eleni
    Demey, Wim
    Janssen, Jan
    Ivanyi, Philipp
    Brouwers, Barbara Anna Henk
    Wynendaele, Wim
    Wang, Lusha
    Kostkova, Lenka
    Hoffman, Jason
    Manzel, Arndt
    Koumarianou, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345